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Physarum polycephalum expresses two closely related, calcium-
independent NOSs (nitric oxide synthases). In our previous work,
we showed that both NOSs are induced during starvation and
apparently play a functional role in sporulation. In the present
study, we characterized the genomic structures of both Physarum
NOSs, expressed both enzymes recombinantly in bacteria and
characterized their biochemical properties. Whereas the overall
genomic organization of Physarum NOS genes is comparable
with various animal NOSs, none of the exon–intron boundaries
are conserved. Recombinant expression of clones with various
N-termini identiﬁed N-terminal amino acids essential for enzyme
activity, but not required for haem binding or dimerization,
and suggests the usage of non-AUG start codons for Physa-
rum NOSs. Biochemical characterization of the two Physarum
isoenzymes revealed different afﬁnities for L-arginine, FMN and
6R-5,6,7,8-tetrahydro-L-biopterin.
Key words: arginine, ﬂavin, haem, nitric oxide synthase (NOS),
Physarum polycephalum,6 R-5,6,7,8-tetrahydro-L-biopterin-
(H4-bip).
INTRODUCTION
Nitricoxide,asignallingandcytotoxic/cytoprotectiveagent,plays
a key role in regulating the nervous, immune and cardiovascular
systems of animals. It is synthesized by NOS (nitric oxide
synthase; EC 1.14.13.39), which occurs as three isoforms and
genes, i.e. NOS1, NOS2 and NOS3, also termed nNOS (neuronal
NOS), iNOS (inducible NOS) and eNOS (endothelial NOS)
respectively. In addition, a number of tissue- and development-
speciﬁc splice variants encoding variant NOS proteins have been
identiﬁed [1–4]. All three NOS isoenzymes are part of a complex
network regulating nitric oxide production in health and disease
(for recent reviews, see [5–9]).
NOSs oxidize L-arginine to L-citrulline and nitric oxide
in an NADPH-dependent reaction via forming N
ω-hydroxy-L-
arginine as an enzyme-bound intermediate [10,11]. The enzymes
consist of an N-terminal oxygenase domain binding haem and a
C-terminal reductase domain binding FMN, FAD and NADPH.
The two domains are linked through a calmodulin-binding motif.
For activity, NOSs are required to form a homodimer leading
to the formation of high-afﬁnity binding sites for H4-bip (6R-
5,6,7,8-tetrahydro-L-biopterin) and L-arginine in each oxygenase
domain, thus allowing for the electron transfer between ﬂavin
and haem groups (reviewed in [12]). Detailed biochemical
and crystallographic studies revealed structural features of the
three isoenzymes underlying the observed differences in dimer
formation and stability caused by L-arginine and H4-bip [13]. In
addition to stabilizing the NOS dimer and affecting the haem
spin state as well as the afﬁnity of NOS for its substrate, H4-bip
also serves as an electron/proton donor for nitric oxide formation,
thereby giving rise to an H4-bip radical [14–16]. Thus the role of
H4-bip in NOS is unique as compared with aromatic amino acid
hydroxylases, the classical H4-bip-dependent enzymes, where the
cofactor activates oxygen by transferring two electrons, thereby
being oxidized and enzymatically recycled after each catalytic
turnover (reviewed in [14,15]). Under conditions of limited H4-
bipavailability,NADPHoxidationbecomesuncoupledfromnitric
oxide synthesis, thus leading to O2
−/H2O2 production [11], a
process involved in certain clinical settings such as endothelial
dysfunction [15].
So far, the ﬁrst and only NOS isolated and cloned from a non-
animal species was found in Physarum polycephalum [17,18].
While many bacteria contain proteins with sequences similar to
mammalian NOS oxygenase domains, these are not full–length
NOSs but lack the reductase domain essential for nitric oxide
production (for a review, see [11]). A deﬁned functional role
for these bacterial NOS oxygenase-like proteins, which are often
termed bacterial NOS, is the nitration of tryptophan [19]. P.
polycephalum is a unicellular model organism expressing two
NOS isoforms (A and B) that share 82% amino acid identity
and are expressed in parallel in the organism throughout various
developmental stages. Starvation strongly induces expression
of both NOSs, which appears to be a prerequisite to obtain
sporulation competence, a process that also involves nitric oxide-
sensitive guanylate cyclase [18]. The overall sequence identity
to mammalian NOSs is less than 39%. Nevertheless, binding
motifs for ﬂavins, NADPH, H4-bip, calmodulin and caveolin are
highly conserved in Physarum NOSs and both proteins resemble
mammalianiNOSlackingthespacersequenceconferringcalcium
dependence [18].
In the present study, we characterized the genomic structures
of both Physarum NOSs and set up bacterial overexpression of
recombinant proteins. This allowed puriﬁcation and biochemical
characterization of Physarum N O S sa sw e l la si d e n t i ﬁ c a t i o n
of the minimal N-terminal sequence being essential for
activity.
Abbreviations used: NOS, nitric oxide synthase; iNOS, inducible NOS; TB, Terriﬁc broth; DTE, dithioerythritol; H4-bip, 6R-5,6,7,8-tetrahydro-L-biopterin;
LB, Luria–Bertani; RACE, rapid ampliﬁcation of cDNA ends.
1 Present address: Institute of Veterinary Biochemistry and Molecular Biology, University of Z¨ urich, Winterthurerstr. 190, CH-8057 Z¨ urich, Switzerland.
2 To whom correspondence should be addressed (email gabriele.werner-felmayer@i-med.ac.at).
The nucleotide sequence data reported will appear in GenBank®, EMBL, DDBJ and GSDB Nucleotide Sequence Databases under the accession
numbers DQ835529, DQ845107, DQ835525, DQ835527, DQ835526 and DQ825528.
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EXPERIMENTAL
Cultivation of P. polycephalum
StrainM3b,aWis1isolateusedinitiallyforpurifyingandcloning
of Physarum N O S ,w a sg r o w ni nas e m i - d e ﬁ n e dm e d i u ma s
detailed previously [18]. The apogamic haploid strain LU352
was kindly provided by Professor Dr Wolfgang Marwan (Max
Planck Institute for Dynamics of Complex Technical Systems,
Magdeburg, Germany) and grown as described in [20]. Amoebae
were generated and grown as described in [21].
RNA isolation and quantitative PCR
RNA from LU352 amoebae and starved macroplasmodia was
isolated using the RNeasy plant mini kit (Qiagen). Physarum
NOS form A and B mRNAs were quantiﬁed using Taqman
technology. Sequences for probes and primers were for NOS
form A: 5
 -ACGCGCACACAGCCAAGAAACG-3
  (probe), 5
 -
CATCCCCGAAACTGTTGCTC-3
  (forward primer), 5
 -GCA-
GTCCGTGGTAGCAACCT-3
  (reverse primer); for NOS form
B: 5
 -CGCAGCGTGCTATCAGCCCAGA-3
  (probe), 5
 -CCAG-
AAGTACACTATTCCATCAGAAATC-3
  (forward primer), 5
 -
GCGGCAATCAGATGTGGATA-3
  (reverse primer). For a refe-
rence, 19 S RNA was quantiﬁed as described in [18].
DNA isolation
DNA from frozen M3b microplasmodia suspended in lysis buffer
was isolated using the DNeasy plant maxi kit (Qiagen) according
to the manufacturer’s instructions and precipitated using sodium
acetateandethanol.DNAwasfurtherpuriﬁedusingtheUltraPure
reagent (Gibco) and precipitated once more with sodium acetate
and ethanol.
PCR, genome walking, cloning and library screening
Genomic structures of Physarum NOSs were elucidated using a
combination of various techniques. First, PCR primer pairs close
to exon/exon boundaries of mammalian NOSs were synthesized
using Physarum NOS cDNA sequences [18] [GenBank®
Nucleotide Sequence Database accession numbers AF145041
(form A) and AF145040 (form B)]. Those regions that could
not be identiﬁed by this approach were identiﬁed by genome
walking using the Universal GenomeWalker kit from Clontech
according to the manufacturer’s instructions. Herculase Hotstart
DNA polymerase (Stratagene) generating an A-overhang was
used for PCR and genome walking, and the generated products
were then cloned into TOPO TA cloning vector (Invitrogen).
Finally,mostgapscouldbeclosedbyscreeningagenomiclibrary
[produced by Professor Tim Burland (McArdle Laboratory for
CancerResearch,UniversityofWisconsin,Madison,WI,U.S.A.)
and kindly provided by Professor Jonatha Gott (Center for RNA
Molecular Biology, Case Western Reserve University, Cleveland,
OH, U.S.A.)] using standard procedures. The library had been
prepared from the LU352 strain by the customer service of
Stratagene by using the LambdaZap vector.
Sequencing and data analysis
Sequencing of clones and plasmids was done by the custom
service of Microsynth (Balgach, Switzerland). Sequence data
were analysed using the Wisconsin Sequence Analysis Package
version 10.3 by the Genetics Computer Group (Accelrys,
Cambridge, U.K.).
Plasmids for the overexpression of Physarum NOSs
Physarum calmodulin cDNA (GenBank® accession number
AB022702) was ampliﬁed using PCR and cloned into site 2 of
the pET-Duet1 vector (Novagen) using EcoRV/XhoI restriction
sites. Physarum NOS form A cDNA (AF145041, cDNA library
clone) was then cloned into site 1 of the pET-Duet1 vector
using SalI/NotI restriction digestion. This sequence included
104 amino acids upstream of the putative start methionine [18],
11 amino acids stemming from the original Bluescript SK
−
vector, and 25 amino acids from the pET-Duet1 vector including
a His tag. Alternatively, Physarum NOS form B (AF145040)
was cloned into the second cloning site of the pET-Duet1 vector
using SacI/NotI restriction digestion. This cDNA started at the
putative start methionine [18] and also contained an N-terminal
His tag. Various N-termini of Physarum NOS form A were
generated by the introduction of an additional SalI site at the
desired position (QuikChange® II kit; Stratagene), cutting by
SalI and re-ligating. Mutations were introduced by site-directed
mutagenesis(QuikChange® IIkit).ForelongatingtheN-terminus
of Physarum NOS form B, 155 bp of the genomic sequence 5
  to
the putative start ATG were introduced using the Infusion cloning
kit (Clontech). This region was conﬁrmed to be identical with
the cDNA 5
 -region generated by RACE (rapid ampliﬁcation of
cDNA ends) PCR (see below). This clone was further modiﬁed
by introducing an additional SacI restriction site at the desired
position (QuikChange® II kit), cutting by SacI and re-ligating,
thus leading to recombinant proteins with various N-termini. In
addition, we introduced an N-terminal StrepTag [22] using the
QuikChange® II protocol into one form of physnosa (A1) and
its almost inactive mutant (A1LD) to allow the preparation of
homogeneous, active proteins.
5  Elongation of cDNA clones
In order to elongate 5
  sequences of the previously published
Physarum NOS form A and B cDNA clones [18], the SMART
RACE cDNA ampliﬁcation kit (Clontech) was used.
Bacterial overexpression of Physarum NOSs and preparation
of homogenates
For overexpression, pET-Duet1 expression plasmids (see above),
grown in NovaBlue (Novagen) cells and puriﬁed by the SNAP
midi prep plasmid preparation kit (Invitrogen), were transformed
into TUNER DE3 cells (Novagen). Bacterial starter cultures
(5 ml) from single colonies were grown in LB (Luria–Bertani)
broth(Difco)withampicillin(50 μg/ml)at37◦Cand220 rev./min
to an attenuance at 600 (D600) of 0.8, and then pelleted and
diluted in 15 ml of fresh TB (Terriﬁc broth) without ampicillin
but supplemented with 1.5% (v/v) ethanol in order to increase
recovery of soluble protein by induction of a heat-shock
response [23]. Aliquots for determining NOS activity at zero
time were taken and cultures were supplemented with 450 μM
5-aminolaevulinic acid (Sigma A-7793) and 3 μM riboﬂavin
(Sigma R-4500), in order to provide sufﬁcient haem and ﬂavins,
and 50 μM IPTG (isopropyl β-D-thiogalactoside). Bacteria were
grown for a further 24 h at 20◦C at 220 rev./min in the dark for
NOS expression. For puriﬁcation, this protocol was scaled up to
30 ml starter cultures and 400 ml expression cultures. TB was
used instead of LB for expression cultures. Bacteria from these
cultures were resuspended in 40 ml of buffer A [50 mM Tris/HCl,
pH 8.0, containing 10% (v/v) glycerol, 25 μM FAD, 25 μM
FMN, 50 μM L-arginine, 5 μMH 4-bip (Schircks Laboratories,
Jona, Switzerland), 5 mM DTE (dithioerythritol), 1 mM PMSF
and 0.2 mg/ml lysozyme]. After incubation for 20 min at 25◦C
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at 200 rev./min, cells were homogenized using a French press
[20000 lbf/in
2 (1 lbf/in
2 =6.9 kPa) twice] and mixed with 110 ml
of buffer B [50 mM Tris/HCl, pH 8.0, containing 10% (v/v)
glycerol, 100 μM L-arginine, 10 μMH 4-bip and 5 mM DTE].
Puriﬁcation of recombinant Physarum NOSs
All steps were carried out at 4◦C and all elution buffers contained
100 μM L-arginine and 10 μMH 4-bip. Protein was precipitated
using 35.6 g of ammonium sulfate (45% saturation) and stirring
for 1 h followed by centrifugation at 48000 g for 20 min. The
pellet was then resuspended in 20 ml of buffer B by stirring for
1 h and undissolved material was collected by centrifugation at
48000 g for 20 min. The supernatant was dialysed twice for 2 h
against 1 litre of buffer B using a 50K membrane (Pierce). The
dialysate was adjusted to 0.15 M NaCl and then incubated (at
4◦C) with 2
 ,5
 -ADP-Sepharose 4B (Amersham Biosciences) for
1 h using a rocking mixer at a ratio of 1 part dialysate protein to 2
parts ADP-Sepharose (w/w). After washing twice with 10 ml of
buffer B containing 0.15 M NaCl and washing once with 10 ml
of buffer B, protein was eluted from ADP-Sepharose with 1 ml
of buffer B containing 10 mM NADPH. Protein determination at
various steps was performed using the Bradford Protein Assay
reagent from Bio-Rad. To obtain homogeneous active protein, the
dimeric fractions of NOS were then collected by gel ﬁltration
on a Superose 12 10/300 GL column (GE Healthcare), and were
ﬁnally puriﬁed using the StrepTag afﬁnity protocol [22].
Native Physarum NOS
Native Physarum NOS was puriﬁed from microplasmodia as
described in [18].
NOS assay
Radiometric citrulline NOS assay was carried out as described
previously [17] using buffer B (see above) supplemented with
2 mMNADPH astheassaybuffer.Brieﬂy,bacterialhomogenates
(bacteria from 2 ml of culture were diluted in 700 μlo fb u f f e rA ,
incubated for 10 min at 25◦C and 1000 rev./min in an Eppendorf
thermomixer and ﬁnally mixed for 10 s with an Ultra-Turrax
homogenizer) or partially puriﬁed NOS (5–20 μl per assay
corresponding to 10–15 μg of protein in the case of bacterial
homogenates or ∼1 μg of protein when using puriﬁed enzyme),
wereincubatedinassaybuffercontaining40000c.p.m.ofHPLC-
puriﬁed
3H-L-arginine (Amersham Biosciences) in a ﬁnal volume
of 200 μl for 10 min at 25◦C on an Eppendorf thermomixer. The
reaction was then stopped, separated on Dowex 50 W columns
and the ﬂow-through was subjected to scintillation counting. In
some assays, concentrations ofcofactors or substrate were varied.
IC50,E C 50 and KM values were calculated with SigmaPlot 9.0
software (Systat Software).
For comparison of nitric oxide formation with NADPH
consumption, a kinetic microtitre-plate assay based on measure-
ment of nitric oxide formation by binding to myoglobin
(monitoredbyUVabsorptionat405 nm)combinedwithmeasure-
ment of NADPH consumption (monitored at 340 nm) was
performedat25◦Casdescribedin[24],usingaPowerWaveXther-
mostatically controlled kinetic microplate reader (BioTek Instru-
ments, Winooski, VT, U.S.A.).
Gel electrophoresis
Proteins were separated on SDS/polyacrylamide gels. Gels were
stainedusingCoomassieBlueorsilverstainaccordingtostandard
proceduresandscannedusinganImageScanner(AmershamBios-
ciences). For quantiﬁcation, gels were stained with Deep Purple
Figure 1 Quantiﬁcation of Physarum NOS form A and form B mRNA levels
TotalRNAwasisolatedfromstarvedmacroplasmodiaofthediploidM3bandthehaploidLU352
strainaswellasfromLU352amoebae,andthetwoNOSformswerequantiﬁedbyTaqmantechno-
logy in relation to 19 S RNA. The means + − S.D. for three independent experiments are shown.
The dashed line indicates the detection limit of the method. Bar 1, M3b macroplasmodia,
Physarum NOS form A; bar 2, M3b macroplasmodia, Physarum NOS form B; bar 3, LU352
macroplasmodia, Physarum NOS form A; bar 4, LU352 macroplasmodia, Physarum NOS form
B; bar 5, LU 352 amoebae, Physarum NOS form A; bar 6, LU352 amoebae, Physarum NOS
form B.
Total Protein Stain (Amersham Biosciences) and ﬂuorescence
wasscannedbyaTyphoon9410scanner(AmershamBiosciences)
at 532 nm and evaluated using ImageQuant software (Amersham
Biosciences).
Determination of haem content by HPLC
HaemcontentofpureformsA1andA1LDwascheckedbyHPLC
according to the method of Bonkovsky et al. [25] by reversed-
phase HPLC separation of porphyrins and UV detection at
405 nm. The suitability of the application of this method for the
analysis of protein-associated haem was conﬁrmed with equine
myoglobin(Serva,Heidelberg,Germany)yielding0.9+ −0.1haem
per myoglobin.
RESULTS
Expression of Physarum NOS form A and B mRNA
We ﬁrst wanted to clarify whether the two highly related Physa-
rum NOS isoforms [18] are the products of two genes or of two
alleles of the same gene, as was shown for the Physarum hapP
gene [26]. For this purpose, we used the haploid Physarum strain
LU352 and checked for the expression of Physarum NOS form A
andBmRNA.BothmRNAswereexpressedinLU352macroplas-
modia starved for 5 days in a way comparable with the diploid
M3bstrain,whichweusedinourinitialstudies[17,18].Moreover,
LU352 amoebae also expressed both mRNAs (Figure 1).
Genomic structures of both Physarum NOSs
We then studied the genomic structures of both Physarum NOSs.
As can be seen from Figure 2(A), 25 exons could be identiﬁed
for Physarum NOS form B. Form A has two additional 5
 
exons as was determined by extending the cDNA into the
5
  direction, a strategy that was not successful for the form
B cDNA where only a shorter 5
  extension could be achieved
starting within an exon (Figure 2A). On the other hand, the exact
number of exons for NOS form A could not be determined since
some internal genomic regions were inaccessible to sequencing
(Figure 2A). However, since all of the 21 exon/intron boundaries
that could be determined were conserved between the two
Physarum NOSs, it is conceivable that the lacking 5 boundaries
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Figure 2 Genomic organization of Physarum NOSs
(A) Exons in cDNAs of human iNOS (bar 1, 27 exons; GenBank® accession numbers for geno-
mic sequence: NT_010799.14; cDNA: NM_000625), chicken iNOS (bar 2, 28 exons; genomic:
NW_060634.1|Gga19_WGA443_1;cDNA:NM_204961),troutiNOS(bar3,27exons;genomic:
AJ295231; cDNA: AJ295230), Physarum NOS form A [bar 4, 27 exons deduced from the
comparison of forms A and B; see the main text for details; genomic: DQ835529 (5 -region, 6
exons),DQ845107(internalregion,5exons),DQ835525(3 -region,9exons);cDNA:DQ835526]
andformB(bar5,27exonsdeducedfromthecomparisonofformsAandB;seethemaintextfor
details; genomic: DQ835527; cDNA: DQ835528). Lines below each bar indicate the translated
region of the cDNA. Positions of various binding sites are marked as have been published
previously [43–47]. For Physarum NOS form A, some internal exon/intron boundaries could
not be determined by sequencing but were deduced from form B. This region is shown in white
and the ﬁve deduced exon/exon boundaries are indicated by a thin line (bar 4). Also, exon 18
could not be fully sequenced. For Physarum NOS form B, the 5 -region could only be partially
extended and starts within an exon (bar 5, indicated by interrupting the margin at the 5 -end),
which was assigned number 3 as deduced from homology to NOS form A. (B)I n t r o ns i z e s
(bp) [GenBank® accession numbers for genomic and cDNA sequences are given under (A)]
fromiNOSgenesofhuman(huminos),chicken(galinos),trout(oncinos)andthetwoPhysarum
NOSs (physnosa; physnosb). ns, not sequenced; –, not identiﬁed.
are also conserved. We therefore concluded that the two genes
consist of 27 exons. For comparison, the gene structures of iNOS
from human, chicken and trout are similarly organized into 27,
28 and 27 exons respectively (Figure 2A). However, none of
the exon/intron boundaries are conserved between Physarum and
the animal iNOSs (Figure 2A). Moreover, the size of introns
in the Physarum genes is considerably smaller compared with
animal NOSs, particularly the human iNOS gene (Figure 2B).
As in other animal iNOSs, the reading frame of the Physarum
NOSs starts in exon 3 (Figure 2A). The current version of the two
genestructureswassubmittedtoGenBank® NucleotideSequence
Database (DQ835529, DQ845107 and DQ835525 for NOS form
A and DQ835527 for NOS form B). The extended cDNA
sequences were also submitted: DQ835526 for NOS form A and
DQ825528forNOSformB.Theﬁnalgenestructureswillbecome
available soon through the ongoing Physarum genome project
(http://www.genome.gov/12511858 and http://genome.wustl.
edu/genome.cgi?GENOME=Physarum%20polycephalum).
Recombinant overexpression of Physarum NOSs in Escherichia coli
Our next goal was to set up efﬁcient recombinant overexpression
of Physarum NOSs in E. coli. In our previous work, we could
functionally express Physarum NOS form A in a baculovirus
system [18], but expression levels were low and did not allow
puriﬁcation of recombinant protein. It is known that high-level
expression of mouse iNOS requires co-expression of calmodulin
[27].WethereforeclonedPhysarumcalmodulinandco-expressed
it together with Physarum NOS forms A and B respectively using
thepET-Duet1vector.IncontrastwiththeoriginalPhysarumNOS
form A cDNA library clone (AF145041) that still contained 104
additionalaminoacids5
  totheputativestartmethionine[18]anda
variantA1,whichcontainedonly29aminoacids5
  totheputative
start, the clone starting at the predicted methionine (A2) had
no enzyme activity (Figure 3A), although it expressed the same
amount of protein (Figure 3D). Elimination of vector-derived
sequences including the His tag resulted in disappearance of both
protein and activity, presumably due to proteolytic degradation
(results not shown). Systematically shortening the N-terminus
5
  to the assumed start methionine then revealed that 13 amino
acids were sufﬁcient to achieve a clone with enzyme activity
(variant A8), which dropped dramatically when one amino acid
(leucine) was deleted (variant A9) and became undetectable
when deleting a further amino acid (variant A3) (Figure 3A).
Exchanging this leucine residue in A1 for aspartic acid or for
glycine (variants A1LD and A1LG) destroyed enzyme activity
almost completely (Figure 3A), whereas it did not affect the
amount of overexpressed protein (Figure 3B), and did not affect
either the haem content of homogeneously puriﬁed proteins (see
below) or the monomer/dimer ratio on gel ﬁltration (results not
shown). Expressing Physarum NOS form B using the predicted
start methionine (clone B) also resulted in an inactive protein,
whereas addition of 50 amino acids 5
  to this methionine (clone
B+) yielded active protein. Varying this N-terminus showed that
only four additional amino acids were sufﬁcient for full activity
of Physarum NOS form B (Figure 3A). As in form A, removal of
a hydrophobic amino acid (leucine for truncation from B6 to B7
andisoleucinefortruncationfromB9toB8)leadstoadecreasein
activity, although the amount of NOS protein in inactive clones is
comparable with that of active clones (Figure 3E). These results
clearly indicated that the N-terminus of both Physarum NOSs
as predicted previously [18] may be too short. In line with this,
comparison of the proteins expressed from the A and B clones
and their variants with native Physarum NOS showed that the
molecular masses of several of these proteins were smaller than
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Figure 3 Overexpression of recombinant Physarum NOSs
(A) N-termini of various clones of Physarum NOS form A and form B and their activity in whole homogenates. Values are means for ﬁve to ten independent experiments (+ −S.D). The previously
predicted start of translation is underlined [18]. All overexpressed proteins start with a His tag sequence (MGSSHHHHHHSQDPNSSSARLQVD), indicated by an ellipsis. Clone A has an additional
GIDKLDIEFRSKG sequence from the Bluescript SK− vector inserted between the His tag and the Physarum NOS sequence. aa, amino acids. (B) Overexpression of A1 and its A1LD mutant.
Homogenates (15μg) harvested at times 0 and 24h after induction were separated on SDS/6% polyacrylamide gels and stained with Coomassie Blue. For the induced cultures of A1 and A1LD,
samplesfromtwodifferentexpressionsareshown.(C)ComparisonofoverexpressedPhysarum NOSfromclonesA,A1andB+(3μgofhomogenateproteinperlane)withnativeNOSpuriﬁedfrom
Physarum microplasmodia (0.3 μg per lane) [18]. Bands were detected by silver staining. Sequencing demonstrated that the second band in native Physarum NOS is a proteolytic fragment of the
ﬁrst one, and that both bands contained a mixture of Physarum NOS form A and Physarum NOS form B [18]. (D) Silver-stained gel of various A clones (homogenates, 3μg of protein per lane). (E)
Silver-stained gel of various B clones (homogenates, 3 μg per lane). Molecular masses (kDa) of several recombinant proteins were calculated for proteins containing the His tag and are given below
the lanes of (C–E).
the native protein, which is a mixture of both isoforms [18]
(Figure 3C).
Checking the elongated Physarum NOS cDNAs showed that
form A cDNA (DQ835526) contained a stop codon 516 bp
upstream of the predicted start ATG but no additional methio-
nine codon, whereas the form B cDNA (DQ835528) had no stop
codon over the whole cloned 740 bp region 5
  to the putative start
codon but encoded for an additional methionine 69 amino acids
upstream of the predicted start [18] (Figure 4A). Starting with
this methionine, the predicted form B protein (Figure 4B) is still
smallerthanthenativePhysarumNOS(Figure3C).Searchingthe
cDNA sequence upstream of the putative start codon showed that
bothPhysarumNOSshaveseveralputativenon-AUGstartcodons
[28,29].AnisoleucineresidueconservedinbothPhysarumNOSs
is found 88 (form A) or 90 (form B) amino acids upstream
(Figure 4A). However, the Kozak sequence for these codons is
less optimal [30] than that of other nearby residues (Figure 4B):
for Physarum NOS form A cDNA, this is the isoleucine codon
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Figure 4 Putative translation start sites in Physarum NOSs
(A) Amino acid sequence predicted from 5  extended cDNA clones of Physarum NOS form A (physnosa, GenBank® accession number DQ835526) and form B (physnosb, DQ835528). Conserved
residuesareshownin boldface.Thepreviouslypredictedstart ofthe protein[18]is framed.An additionalmethioninein form Bis markedbyagreyarrow,andputative alternativestarts ofthereading
frames are indicated by black arrows. Numbers in italics refer to amino acid positions related to the previously predicted reading frames [18], and normal numbers refer to amino acids deduced from
the 5  extended cDNA clones (DQ835526 and DQ835528). The asterisk denotes the stop found in the Physarum NOS form A cDNA. (B) Molecular mass for Physarum NOSs with various starts
andtheKozaksequencesoftheirputativestartcodons.Putativestartcodonsarewritteninlower-caseletters,whereasthecontextfortranslationisgiveninupper-caseletters.Thenucleotidepositions
as well as the amino acid positions given in parentheses refer to GenBank® sequences DQ835526 and DQ835528. Amino acid positions not in brackets refer to the previously predicted reading
frame [18] starting with methionine 1. The asterisk indicates previously published data [18].
(ATT) at amino acid position –97; for Physarum NOS form B,
an alternative start codon (ATT) with a nearly optimal context is
encodingisoleucineinposition–108.Thesesitesyieldproteinsof
nearly identical molecular mass (Figure 4B) that are comparable
with that of native NOS (Figure 3C).
Enzymatic properties of recombinant Physarum NOSs
We then characterized enzymatic properties of recombinant
Physarum NOSs. For this purpose, we used proteins expressed
fromtheA1andB+clonepartiallypuriﬁedbyammoniumsulfate
precipitation and subsequent ADP-Sepharose-afﬁnity chromato-
graphy.ThisprocedureyieldedNOSwithapprox.80%purity(cf.
Figure 5A, last lane). The speciﬁc activity was 244+ −47 nmol·
mg
−1 ·min
−1 (form A, mean for three puriﬁcations + − S.D.) and
253+ −47 nmol·mg
−1 ·min
−1 (form B, mean for four 4 puriﬁ-
cations + − S.D.). Figure 5 shows a typical puriﬁcation of A1 re-
combinantprotein.WhilebothPhysarumNOSswerecomparably
sensitive to NOS inhibitors and similarly dependent on NADPH
and FAD, and had similar dimer/monomer ratios of approx. 1:1
on gel ﬁltration (Figures 6A and 6B), the KM for L-arginine
and the EC50 for FMN and H4-bip were clearly higher for NOS
form A than for the form B protein (Table 1). A combined
nitric oxide formation (determined by binding to myoglobin)
and NADPH molecules consumption assay [24] showed partial
decoupling of the enzyme preparations, with 5.1+ −1.6 NADPH
molecules consumed in the formation of 1 nitric oxide molecule
byPhysarumNOSAand5.9+ −1.5NADPHmoleculesconsumed
per nitric oxide molecule in Physarum NOS B (mean + − S.D. for
three determinations).
Haem content of homogeneous Physarum NOSs A1 and A1LD
To check whether or not the mutation of a residue in the
N-terminus that led to a pronounced decrease in activity also
affected haem binding and hence haem content of the active
enzyme,weintroducedintoformsA1andA1LD(seeFigure3A)a
StrepTag,andfurtherpuriﬁedthetaggedproteinsbyadditionalgel
ﬁltration, collection of the dimeric fractions and ﬁnal puriﬁcation
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Figure 5 Partial puriﬁcation of recombinant Physarum NOS form A (clone
A1)
(A) Coomassie-Blue-stained SDS/polyacrylamide gel (6–17% gradient) showing partial
puriﬁcationofrecombinantPhysarum NOSformAcloneA1.Theamountoftotalproteinloaded
per lane was 20μg. Homogenate, whole bacterial homogenate; supernatant, supernatant after
loading the 2 ,5 -ADP-Sepharose 4B column; wash, ﬁrst wash of 2 ,5 -ADP-Sepharose 4B
with buffer B; eluate, protein eluted from 2 ,5 -ADP-Sepharose 4B with buffer B containing
10 mM NADPH. The ammonium sulfate precipitation step is not shown. (B) Activities, yield
and puriﬁcation factor of Physarum NOS form A clone A1 protein puriﬁed from 400ml
of bacterial culture (homogenate) by ammonium sulfate precipitation (AS precipitation) and
2 ,5 -ADP-Sepharose 4B afﬁnity chromatography (2 5-ADP).
Table 1 Enzymatic properties of recombinant Physarum NOSs
Partially puriﬁed recombinant Physarum NOS form A (clone A1) and form B (clone B+), each
of them with an activity of approx. 250nmol·mg−1 ·min−1 (see text for data), were used for
measuring substrate, cofactor and inhibitor effects. L-NIL, L-N6(1-iminoethyl)-lysine; L-NNA,
Nω-nitro-L-arginine; L-NMMA, Nω-methyl-L-arginine. Values are means + − S.D. for three to
ﬁve independent experiments. Values in boldface are signiﬁcantly different (Student’s t test)
between NOS form A and form B: KM L-arginine, P <0.001; EC50 H4-bip, P <0.001; EC50
FMN, P <0.02.
Concentration (μM)
Physarum NOS A Physarum NOS B
KM L-arginine 66.7+ −14.5 26.8+ −9.7
EC50 H4-bip 7.9 + −1.2 0.7+ −0.1
EC50 NADPH 57.2+ −6.5 60.3+ −13.8
EC50 FAD 3.9 + −1.6 2.1+ −1.6
EC50 FMN 1.7+ −0.6 0.2+ −0.2
IC50 L-NIL 81.3+ −7.8 76.7+ −4.3
IC50 L-NNA 25.7+ −10.7 39.8+ −20.3
IC50 L-NMMA 45.2+ −23.5 44.3+ −19.2
using the StrepTag afﬁnity column. This yielded a homogeneous
protein (>95% SDS gel silver–stained; Figure 6C) free of
E. coli impurities (minor impurities also contain the StrepTag
as checked by Western blotting). Pure A1 (three preparations)
had a speciﬁc activity of 585+ −144 nmol·mg
−1 ·min
−1,a n da
haem content of 0.41+ −0.14 haem per subunit, whereas pure
A1LD (two preparations) displayed less than one-tenth of the
activity (51+ −10 nmol·mg
−1 ·min
−1), but had a haem content
(0.44+ −0.09 per subunit) comparable with A1 (Table 2).
DISCUSSION
P.polycephalum,amemberoftheclass/superclassMyxogastridae
(also termed myxomycetes or true slime molds), is the only so
far identiﬁed non-animal species known to express NOS with the
characteristics of mammalian iNOS [17]. Previously, we showed
that this enzyme is induced by starvation of macroplasmodia
and plays a crucial role in sporulation [18]. Cloning experiments
indicated that Physarum contains two highly related calcium-
independentNOSs(formsAandB,82%aminoacididentity)that
areexpressedinparallelthroughoutvariousdevelopmentalstages
and have a similar molecular mass, as was not only deduced from
the cDNA sequences but was underlined by the fact that puriﬁed
native Physarum NOS was a mixture of both proteins that were
not separated by SDS/PAGE [18]. While parallel expression
of calcium-dependent and calcium-independent NOS isoforms
withinacertaincelltypeiscommoninanimalspecies,theparallel
occurrence of two versions of calcium-independent NOS has not
been reported, at least to our knowledge. The previously used
Physarum strain was the diploid M3b isolate. Thus it was possible
that the two different cDNAs and proteins could stem from two
alleles of the same gene, as it was described for the plasmodium-
speciﬁc hapP mRNA that encodes proteins of unknown function
differingby9.6%intheirpredictedaminoacidsequence[26].We
therefore checked for expression of Physarum NOS form A and
formBinthehaploidPhysarumstrainLU352[23],thestrainnow
being used for sequencing the Physarum genome (http://www.
genome.gov/12511858andhttp://genome.wustl.edu/genome.cgi?
GENOME=Physarum%20polycephalum). Quantifying Physa-
rum NOS form A and form B expression in starved macro-
plasmodia of both strains showed comparable mRNA levels.
Moreover, both mRNAs were also expressed in LU352 amoebae.
Macroplasmodia of diploid strains develop after fusion of geneti-
cally different amoebae, but in the apogamic haploid strains
like LU352 no such fusion is required [21,30]. Therefore
expression of both NOS mRNAs in LU352 amoebae underlined
the assumption that the two Physarum NOS forms stem from two
genes rather than from two alleles of the same gene.
Studying the organization of these two genes revealed the
high similarity of the overall structure of the Physarum NOS
genes to those of NOS genes from higher animals including
mammals. Intron size of Physarum NOSs is smaller than that
of animal NOSs, which is in agreement with the smaller genome
size of Physarum (300 Mb [30a,30b]) as compared with human
(3038 Mb) or chicken (1200 Mb; http://www.ncbi.nlm.nih.gov/
genomes/leuks.cgi)[31].Noneoftheintronpositionsisconserved
between Physarum and animal NOS genes, which is in line with
the idea that introns are transposable elements that are acquired
or also deleted during evolution (reviewed in [32]). Transposition
of introns occurs very infrequently during evolution; for example,
most orthologous genes between mouse and human, species
that diverged at least 50 million years ago, have the same
intron positions [32]. This gives some idea of the evolutionary
distance between Physarum and higher animals and their early
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Figure 6 Gel ﬁltration of puriﬁed Physarum NOSs
Physarum NOS isoforms (clones A1 and B+ respectively) carrying an N-terminal Strep tag were expressed together with Physarum calmodulin in E. coli using the pETDuet1 vector (see the
Experimentalsectionfordetails).A200μlportionofpuriﬁedproteinwasthenloadedontoaSuperose1210/300GLgelﬁltrationcolumnandelutedwithbufferBcontaining0.15MNaCl.Fractions
werecollectedandNOSactivitywasdeterminedbytheradiometriccitrullineassay.ThesolidlineshowsUVabsorption(OD)at280nm,thedashedlineshowsNOSactivity.Arrowsindicatetheelution
volume of protein standards for gel ﬁltration (thyreoglobulin, 690kDa; β-amylase, 200kDa; albumin, 67kDa). (A) Physarum NOS A; (B) Physarum NOS B; (C) silver-stained SDS gel showing the
purity of Strep-tagged Physarum NOS A.
Table 2 Original data for haem determination of pure Physarum NOS preparations
Physarum NOS clones A1 and A1LD containing an N-terminal Strep tag were co-expressed with Physarum calmodulin in E. coli with pETDuet1 and puriﬁed by ammonium sulfate fractionation,
ADP-Sepharose-afﬁnity chromatography, gel ﬁltration and Strep-tag-afﬁnity chromatography. Haem was determined in puriﬁed fractions by reversed-phase HPLC with UV detection. NOS activity
wasdeterminedbytheradiometriccitrullineassay.ProteinwasdeterminedbytheBradfordassayusingBSAasthestandard.MM,calculatedmolecularmass.SeetheExperimentalsectionfordetails
of the method.
Sample Batch Haem (μM) Protein (mg/ml) MM (kDa) Haem/subunit NOS activity (nmol·mg−1 ·min−1)
NOSA1 1 2.57 1.30 126 0.25 768
NOSA1 2 7.47 2.32 126 0.41 417
NOSA1 3 4.71 1.02 126 0.58 569
NOSA1-LD 1 5.01 1.80 126 0.35 41
NOSA1-LD 2 4.16 1.00 126 0.52 61
divergence from a common ancestor (see below) where already
some ancestral NOS had evolved. Once the ﬁnal Physarum
genome sequence is available, these speculations can be studied
in more detail and it will also be possible to clarify whether the
two Physarum NOS genes stem from single gene duplication or
other evolutionary events.
Some further interesting aspects with regard to evolution
become evident here. According to molecular phylogenetic data,
Physarum is most closely related to the cellular slime moulds, the
Dictyostelidae [33,34]. Together with other amoebae and slime
mould classes, they are grouped as Amoebozoa, one of eight
major groups composing the ‘crown’ of the phylogenetic tree of
eukaryotes [33,35], thus indicating that these organisms cannot
be considered as ‘low’ stages on the path to higher animals and
fungi but have developed independently from a more ancient,
not yet deﬁned, root [35]. However, a more reﬁned analysis of
evolutionary relationships between Physarum and Dictyostelium,
another model organism for cell biology, has to await the ﬁnal
Physarum genome. In any case, our results on NOS as well
as previous observations concerning pteridine biosynthesis (see
below) underline the diversity of Physarum and Dictyostelium
despite the striking similarities of their life cycle, the occurrence
of mobile and stationary developmental stages, their habitat
and their way of feeding as well as the fact that their protein
sequences usually group on a common branch in phylogenetic
analysis. First of all, Dictyostelium discoideum does not contain
any gene similar to full-length NOS (as checked by BLAST-P
search of the Dictyostelium genome with the Physarum NOSs;
results not shown), whereas Physarum contains two genes with
exon numbers comparable with those of higher animals (see
Figure 2) and an even intron distribution characteristic of higher
eukaryotes[36].Secondly,DictyosteliumdoesnotproduceH4-bip
like Physarum [17] but its stereoisomer tetrahydrodictyopterin
[37], a pterin that cannot serve as a cofactor for mammalian NOS
[38]orPhysarumNOS(E.R.Werner,G.Golderer,P.Gr¨ obnerand
G. Werner-Felmayer, unpublished work). Moreover, the genomic
structures of GTP cyclohydrolase I, the ﬁrst enzyme of H4-bip
biosynthesis, differ signiﬁcantly between the two species [39]:
in accordance with its comparatively small genome of 34 Mb
(http://www.ncbi.nlm.nih.gov/genomes/leuks.cgi),Dictyostelium
has only one 109 bp intron [40], whose location is conserved in
Physarum, whereas the Physarum gene consists of 7 exons and
thus resembles animal GTP cyclohydrolase I genes with some
intron positions conserved in Drosophila or human. In addition,
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alternative splicing of GTP cyclohydrolase I occurs in Physarum
at a similar position to human [39]. Taken together, these ﬁndings
suggest that Physarum may be more closely related to animals
than Dictyostelium with respect of H4-bip and nitric oxide
synthesis, and it underlines the value of Physarum as a model
system for studying certain aspects of animal cell biology. In line
with our observations, the recent analysis of Physarum expressed
sequence tags [41] has revealed 895 genes of Physarum with
similarities in other databases but not in the Dictyostelium protein
database. In addition, approx. 9% of all detected genes are
alternatively spliced in Physarum, whereas only approx. 0.2%
of genes are alternatively spliced in Dictyostelium [41].
In the course of setting up recombinant expression of both
Physarum NOSs in bacteria, we found that the previously predic-
ted reading frame [18] was too short at its N-terminus. We con-
cludedthisnotonlyfromlackofactivityofHis-taggedexpression
constructs, but also from the smaller size of the recombinant
proteinsascomparedwiththenativeNOSpuriﬁedfromPhysarum
microplasmodia (Figure 3C). Addition of only a few amino acids
(13 for NOS form A and four for NOS form B) to the N-terminus
as deduced from the cDNAs led to expression of functional
proteins. Producing 5
 -extended cDNA sequences for both NOSs
and checking for other possible translation starts revealed that
only NOS form B had an upstream methionine within reasonable
distance, whereas for NOS form A we found a stop codon and
no additional AUG codons between this stop and the previously
predicted start. Thus at least NOS form A appears to use a non-
AUG start codon [29] and this may also be the case for NOS
form B. The molecular masses of the predicted NOSs star-
tingfromthesealternativestartcodons(bothencodingisoleucine)
compare much better with native NOS than those of the proteins
starting with the ﬁrst encoded AUG codon. It should be noted
that none of the possible AUG codons have an optimal context,
whereas the predicted alternative non-AUG codons, particularly
of NOS form B, ﬁt much better to this rule [29]. Future studies
will clarify the exact start of Physarum NOS proteins, but at least
NOS form A and presumably also form B appear to belong to the
growing group of mRNAs with non-AUG translation initiation
[29]. Sometimes, as was shown for the mammalian translational
regulator EIF4G2 (eukaryotic translation initiation factor 4γ2)
[28], usage of a non-AUG translation initiation site is even
conserved evolutionarily. However, there is no report that any of
the animal NOS mRNAs starts translation at a non-AUG codon.
Although the two isoforms of Physarum NOS are highly
similar, we found distinct differences in the enzymology of
the recombinant proteins expressed in E. coli. Physarum NOS
form B has a signiﬁcantly higher afﬁnity towards L-arginine,
H4-bip and FMN than Physarum NOS form A. The puriﬁed
recombinant proteins of form A and B contained about the same
amount of dimer and monomer, and were partly decoupled in that
they consumed more than 5 NADPH molecules per nitric oxide
molecule formed rather than 1.5 NADPH molecules per nitric
oxide molecule for the fully coupled mammalian enzyme [11].
We were surprised to ﬁnd the requirement of N-terminal amino
acidresiduesupstreamoftheﬁrstAUGcodonsincethisisaregion
with low homology with other NOSs, and a region that iNOS
oxygenase domains apparently do not require for function [42].
In iNOS oxygenase domain crystals, this region is disordered
[43] so that no structural information on this region is available to
date. After we had determined the minimum amount of residues
required to yield a functional recombinant protein, we mutated
the amino acid on the truncation of which the activity was lost,
a leucine residue, in a larger construct to investigate whether
we simply required a certain length of the protein, or whether
speciﬁc residues were needed. Activity was lost on mutation of
this leucine residue to aspartate or glycine, without affecting the
monomer/dimer ratio and the haem content of homogeneously
puriﬁed proteins. We assume that speciﬁc residues in this region
are possibly required for interactions between oxygenase and
reductase domains in the dimer of the enzyme, for which hydro-
phobic forces might be crucial.
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